- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 497364, 7 pages
Immunogenicity of a Recombinant Influenza Virus Bearing Both the CD4+ and CD8+ T Cell Epitopes of Ovalbumin
1Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy
2Department of Biology and Biotechnology “Charles Darwin”, University of Rome “La Sapienza”, 00185 Rome, Italy
3Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, WI 53706, USA
4Division of Virology, Department of Microbiology and Immunology, and International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
5ERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama 332-0012, Japan
Received 28 June 2011; Revised 5 August 2011; Accepted 10 August 2011
Academic Editor: Zhengguo Xiao
Copyright © 2011 Bruno Garulli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- A. García-Sastre, “Transfectant influenza viruses as antigen delivery vectors,” Advances in Virus Research, vol. 55, pp. 579–597, 2000.
- B. Ferko, J. Stasakova, S. Sereinig et al., “Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice,” Journal of Virology, vol. 75, no. 19, pp. 8899–8908, 2001.
- A. V. Machado, N. Naffakh, S. van der Werf, and N. Escriou, “Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter,” Virology, vol. 313, no. 1, pp. 235–249, 2003.
- K. Shinya, Y. Fujii, H. Ito, T. Ito, and Y. Kawaoka, “Characterization of a neuraminidase-deficient influenza A virus as a potential gene delivery vector and a live vaccine,” Journal of Virology, vol. 78, no. 6, pp. 3083–3088, 2004.
- Q. Gao, A. C. Lowen, T. T. Wang, and P. Palese, “A nine-segment influenza A virus carrying subtype H1 and H3 hemagglutinins,” Journal of Virology, vol. 84, no. 16, pp. 8062–8071, 2010.
- B. J. G. Baaten, C. R. Li, M. F. Deiro, M. M. Lin, P. J. Linton, and L. M. Bradley, “CD44 regulates survival and memory development in Th1 cells,” Immunity, vol. 32, no. 1, pp. 104–115, 2010.
- T. J. Chapman, M. R. Castrucci, R. C. Padrick, L. M. Bradley, and D. J. Topham, “Antigen-specific and non-specific CD4+ T cell recruitment and proliferation during influenza infection,” Virology, vol. 340, no. 2, pp. 296–306, 2005.
- M. Coccoris, E. Swart, M. A. de Witte et al., “Long-term functionality of TCR-transduced T cells in vivo,” Journal of Immunology, vol. 180, no. 10, pp. 6536–6543, 2008.
- C. H. GeurtsvanKessel, M. A. M. Willart, L. S. van Rijt et al., “Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells,” Journal of Experimental Medicine, vol. 205, no. 7, pp. 1621–1634, 2008.
- K. M. Grebe, H. D. Hickman, K. R. Irvine, K. Takeda, J. R. Bennink, and J. W. Yewdell, “Sympathetic nervous system control of anti-influenza CD8+ T cell responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 13, pp. 5300–5305, 2009.
- M. R. Jenkins, R. Webby, P. C. Doherty, and S. J. Turner, “Addition of a prominent epitope affects influenza A virus-specific CD8+ T cell immunodominance hierarchies when antigen is limiting,” Journal of Immunology, vol. 177, no. 5, pp. 2917–2925, 2006.
- D. J. Topham, M. R. Castrucci, F. S. Wingo, G. T. Belz, and P. C. Doherty, “The role of antigen in the localization of naive, acutely activated, and memory CD8+ T cells to the lung during influenza pneumonia,” Journal of Immunology, vol. 167, no. 12, pp. 6983–6990, 2001.
- T. Hatziioannou, E. Delahaye, F. Martin, S. J. Russell, and F. L. Cosset, “Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin,” Human Gene Therapy, vol. 10, no. 9, pp. 1533–1544, 1999.
- Z. N. Li, S. N. Mueller, L. Ye et al., “Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity,” Journal of Virology, vol. 79, no. 15, pp. 10003–10012, 2005.
- W. A. Langley, K. C. Bradley, Z. N. Li, M. E. Smith, M. J. Schnell, and D. A. Steinhauer, “Induction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathways,” Journal of Virology, vol. 84, no. 16, pp. 8300–8307, 2010.
- G. Neumann, T. Watanabe, H. Ito et al., “Generation of influenza A viruses entirely from cloned cDNAs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 16, pp. 9345–9350, 1999.
- A. Bender, L. K. Bui, M. A. V. Feldman, M. Larsson, and N. Bhardwaj, “Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses,” Journal of Experimental Medicine, vol. 182, no. 6, pp. 1663–1671, 1995.
- P. Bilsel, M. R. Castrucci, and Y. Kawaoka, “Mutations in the cytoplasmic tail of influenza A virus neuraminidase affect incorporation into virions,” Journal of Virology, vol. 67, no. 11, pp. 6762–6767, 1993.
- M. Li, G. M. Davey, R. M. Sutherland et al., “Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo,” Journal of Immunology, vol. 166, no. 10, pp. 6099–6103, 2001.
- S. Mandl, L. J. Sigal, K. L. Rock, and R. Andino, “Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 14, pp. 8216–8221, 1998.
- A. McAllister, A. E. Arbetman, S. Mandl, C. Pena-Rossi, and R. Andino, “Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases,” Journal of Virology, vol. 74, no. 19, pp. 9197–9205, 2000.
- N. P. Restifo, D. R. Surman, H. Zheng, P. Palese, S. A. Rosenberg, and A. García-Sastre, “Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer,” Virology, vol. 249, no. 1, pp. 89–97, 1998.
- H. Zheng, P. Palese, and A. García-Sastre, “Antitumor properties of influenza virus vectors,” Cancer Research, vol. 60, no. 24, pp. 6972–6976, 2000.
- C. Moser, M. Amacker, A. R. Kammer, S. Rasi, N. Westerfeld, and R. Zurbriggen, “Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations,” Expert Review of Vaccines, vol. 6, no. 5, pp. 711–721, 2007.
- I. Marigo, L. Dolcetti, P. Serafini, P. Zanovello, and V. Bronte, “Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells,” Immunological Reviews, vol. 222, no. 1, pp. 162–179, 2008.
- M. W. L. Teng, J. B. Swann, C. M. Koebel, R. D. Schreiber, and M. J. Smyth, “Immune-mediated dormancy: an equilibrium with cancer,” Journal of Leukocyte Biology, vol. 84, no. 4, pp. 988–993, 2008.